Sun et al. [31] reported the significant downregulation of MEG3 in lung and pulmonary arteries of patients with PAH and MEG3 knockdown affected PASMC proliferation and migration in vitro. This evidence concerns the gene MEG3 and pulmonary arterial hypertension.